chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Novocaine at dentist office for a routine procedure took 12 hours to wear off (usually takes 2-4 hours) 2 days after booster I have also had internal tremors that started a week or two after the shot and are finally subsiding. I have a very good friend who, like me, is very healthy, active and fit who also got internal tremors after her Moderna vaccine. She also has had unexplained muscle spasms and had had a full neurological workup with no significant findings All three of my boosters triggered a minor psoriasis inflammation (I do not typically have psoriasis) I am thrilled that I am vaccinated and would suffer through these adverse effects again if required. I am just reporting them because I believe the vaccines are triggering more symptoms in people than doctors might be associating with the shots
03/12/2021 sore arm and fatigue  03/13/2021 chills, low grade fever (100f), aches, fatigue  03/14/2021 fatigue but no other symptoms
Information has been received from a health professional concerning a 9 year old female child who on 06/07/1996 was vaccinated SC in the right arm with a first dose of varicella virus vaccine live. On 01/08/2002 the child developed a rash which was classified as chickenpox. The outcome of the chickenpox was not reported. It was noted that the child was exposed to her sibling (WAES0201USA02950) who developed chickenpox 12 days earlier. Another sibling (WAS0201USA02949) also developed chickenpox following exposure to varicella virus vaccine live. No further info is available.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 21-DEC-2015, the patient was vaccinated with expired first dose M-M-R II lot # J013131 and expiry date of 17-OCT-2015 (unknown route and dose). No adverse symptoms were reported. Additional information has been requested.
Concomitant products included VITAMINS NOS for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site). On 21-Jan-2021, the patient experienced LYMPHADENOPATHY (lymph nodes swollen at her neck 1 first and now 3). At the time of the report, LYMPHADENOPATHY (lymph nodes swollen at her neck 1 first and now 3), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications also included high blood pressure medication (an ACE inhibitor)  Treatment medication included alcohol used to treat lymph nodes.
slept for 5 hours in the middle of the day; This spontaneous case was reported by a patient and describes the occurrence of SOMNOLENCE (slept for 5 hours in the middle of the day) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.    Co-suspect product included non-company product IBUPROFEN for an unknown indication.    No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started IBUPROFEN (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced SOMNOLENCE (slept for 5 hours in the middle of the day). At the time of the report, SOMNOLENCE (slept for 5 hours in the middle of the day) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-214496 (Patient Link).
Severe pain in my neck going down through my shoulder and around my right arm at the injection site.  Pain started on November 21 and has continued through and is still current now.  I have tried treating with over the counter medication, Aleve, and prescription muscle relaxer (Flexeril) and have not been able to find any relief.  I have also experienced pain in my lymph node in my right arm pit of the injection site.  This pain has subsided.  I did not experience any of these side effects with the Pfizer vaccination.  This was the booster shot.
Developed maculo-papular rash 36 hours after AVA #2. Symptoms continue to present. Itching. Lesions on posterior and anterior legs, both forearms and scattered patches on her back. She describes the lesions as individualized, dry, pruritic, having an erythematous base and resembling mosquito bites. Hot showers make them worse, little makes them better. Assessment: Chronic pruritic dermatitis temporally associated with anthrax vaccine #2. The follow up received on 12/31/03 states numular eczema has remained active in spite of prednisone course, UVB light treatments and many topical preparations. Member was patch tested to the components of the anthrax vaccine but tested negatively except for a possible allergic repsponse to formaldehyde. Pt reports that symptoms have worsened on the upper extremities.
This spontaneous report was received from a physician via company representative regarding a 30 year old female patient. The patient's pertinent medical history, concomitant medication, drug reaction and allergies were unknown. On an unknown date, the patient was vaccinated with GARDASIL (strength, dose, route, lot# and expiry date were unknown) for prevention of human papillomavirus (HPV) (prophylaxis). The patient received a three-dose series of GARDASIL when she was 18 years old. On an unknown date, the patient was tested for HPV infection during a routine gynecological exam and the results showed that she was positive for HPV 18 (papilloma viral infection). The patient was not received any treatment for the event. Product quality complaint was not involved. No additional information was available. The outcome of papilloma viral infection was not recovered/not resolved. The causality assessment for the event was not provided.
This spontaneous report as received from a nurse refers to an 8 months and 30 dyas old male patient. No concurrent condition, medical histtory or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product qualitty complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
I started feeling pain in my shoulders and hips to the point that it was painful to raise my arms, and sit down. and turn in bed in December 2021  I was started on Predisone 15 mg  in Dec 2021 and am now on a weaning dose  dropping 1 mg every two weeks.  I still have pain but it is manageable. I have had a battery of tests and everything has come back negative. No signs of PMR. Dr.   feels it is an adverse reaction to my Covid Booster vaccine
pt mom called to report 3hr p/vax pt turned light blue & had funny movements;noted also that pt had vomited prior to immun d/t a change in formula according to mom;
COVID-19 symptoms from 6/12/2022 to 6/14/2022.
Swelling of left upper arm.  Thing appeared 01/11/04.   Then died spontaneously arm normal on 01/12/04.
This case was reported by a nurse via sales rep and described the occurrence of edema hands in a 60-year-old female patient who received SHINGRIX. Concurrent medical conditions included rheumatoid arthritis. Concomitant products included methotrexate. On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a day after receiving SHINGRIX, the patient experienced edema hands and fever. On an unknown date, the outcome of the edema hands was recovering/resolving and the outcome of the fever was unknown. It was unknown if the reporter considered the edema hands and fever to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received SHINGRIX on unknown arm. The patient did have rheumatoid arthritis and was on Methotrexate at the reporting time. The patient described it as more as a rise of the skin and also had a low grade fever. The patient told the administrator that swelling had decreased somewhat the next day.
PT tested positive for COVID after being fully vaccinated. She received Dose #2 on 3/26 (ER8733) Then tested positive during routine testing for a procedure on 5/11/21. Pt was asymptomatic.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported. On an unknown date, the patient was inadvertently vaccinated with improperly stored GARDASIL 9 lot# N019103, expiration date on 03-FEB-2020 (exact dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 47 Fahrenheit degrees to 77 Fahrenheit degrees for 30 minutes. There were no previous excursions reported. The digital data logger was involved. This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-1806USA011514:
This spontaneous report was received from a Registered Nurse via company representative regarding to a female patient of unknown age. The patient's pertinent medical history and concurrent conditions were not reported. It was reported that nurse was told by patient that she had never received PNEUMOVAX 23. On an unknown date in 2016 the patient received second dose of PNEUMOVAX 23, lot, dosing details and route unknown. However, nurse found out that the patient had been vaccinated with first dose of PNEUMOVAX 23 two years ago on an unknown date in 2014 (inappropriate schedule of vaccine administered). Concomitant medication were not reported. No adverse effects were reported. Product quality complaint was not filed (PQC). Additional information is  not expected as the reporter did not wish to contact further.
Mother states child broke out in a rash. First started on 6-24-12 as small red spots on chest and belly, but by the end of the day, rash was all over body and had turned to welts. Reaction continued to get worse. Saw ER on 6-24-12, they just diagnosed with a rash and said it would get better- no treatment provided. Saw ER on 6-25-12, they just diagnosed with Rosacea- no treatment provided. Patient was seen by PCP on 6-26-12 and they said it was an allergic reaction to vaccines given on 6-12-12. They administered a steroid shot and gave a rx for Benadryl. Child also had a temp of 100 on morning of 6-26-12 so they instructed mom to give Tylenol. PCP also told mother that child's left eardrum was red, but didn't say it was an ear infection.
making sleepy / went to sleep between 1400 and 1800; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (making sleepy / went to sleep between 1400 and 1800) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced SOMNOLENCE (making sleepy / went to sleep between 1400 and 1800). On 06-May-2021, SOMNOLENCE (making sleepy / went to sleep between 1400 and 1800) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
approx 2 1/2 wks p/vax broke out in fine generalized rash (septemic) w/loss of appetite, moderate irritability; rash lasted 2-3 days; took to pediatrician who dx it as a viral rash;
This spontaneous report as received from a healthcare worker (pharmacy technician) refers to a patient of unknown age and gender. Medical history and concurrent conditions were not provided. The healthcare worker reported a "particular" (product physical issue), in a reconstituted vial of ZOSTAVAX lot number and expiry date were not reported. So on an unknown date, that caused the patient to miss their vaccination. No adverse effects reported. PQC had been filed. There was no concomitant medication provided. Additional information has been requested.
area of painless swelling/effusion to posterior wrists/hands b/l  started the day after receiving 2nd covid-19 vaccine
Vaccine administer after the 31 day refrigeration date but before the 45 day excursion time.
lt thigh abscess devel 1 day p/vax;drained thick yellow pus p/7 days 5MAY98;now is healing w/pt on ATB;
3 inch swollen raised circle at shot site; stayed hard and red for 10 days; remained painful to touch; slowly decreased in size but did stay hard on surface of leg for 15 days!
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild
Pain, tingling, tightness in the arm and legs and back; shakiness.  Emergency personnel were notified. Paramedics assessed patient.
appendicitis; felt horrible; had an excruciating headache; Prev dose administration date 30Aug2021. Most recent vaccine administration date 23Oct2021; This is a spontaneous report from a contactable consumer (patient).  A 22-Year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number FH8020, on 23Oct2021 10:30 at single dose in right arm (at the age of 22-Year-old) for COVID-19 immunisation. Medical history was not reported. Concomitant medication was none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received first dose of BNT162B2 Batch/Lot No: EW0196 on 30Aug2021 03:30 AM in right arm.  The patient was not diagnosed with COVID-19 prior to vaccination. Less than 2 days after receiving the second dose on 24Oct2021 06:00, the patient was diagnosed with appendicitis and had to undergo emergency surgery to remove his appendix. He had never experienced issues until the shot. He also felt horrible and had an excruciating headache after receiving the vaccine. The event appendicitis was serious with life-threatening, hospitalization and disability. The events appendicitis, felt horrible and headache resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient had been tested for COVID-19 since the vaccination. Lab data on 25Oct2021 included: Nasal Swab negative. The outcome of the events appendicitis, felt horrible and headache was not resolved.  No follow-up attempts are possible. No further information is expected.
A couple hours after shot, patient felt like her throat was swelling but could breathe fine out of her nose. Began coughing for a few hours and then went to the emergency room. She was given BENADRYL and is doing better the next day.
Dizziness, Headache, Myalgia, STOMACH ACHE, CHILLS Narrative:
PATIENT WAS GIVEN MONOVALENT VACCINE INSTEAD OF BIVALENT VACCINE
After he exercises ever since he received the vaccine, he has been getting exercise induced urticaria that lasts for 1-2 hours and is moderately pruritic. He said he feels as red as a lobster for an hour or two before it goes away.
a temperature excursion; no additional adverse events were reported; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On an unknown date, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (lot#: W039294, expiration date: 11-DEC-2024; strength, dose, and route of administration were not provided) by a health professional for prophylaxis. The vaccine administered experienced temperature excursion before, which was improperly stored at 17.4F for 2 hours (product storage error). No additional adverse events were reported (no adverse event).
Father noticed swelling of bottom lip 20 minutes after vaccines received. Bottom lip continued swelling until transported to ER by EMS.
It is hard; Red; Itching; felt tired; Swelling; Hot to touch; little bit of soreness; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch), VACCINATION SITE PAIN (little bit of soreness), VACCINATION SITE INDURATION (It is hard), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE PRURITUS (Itching) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history information reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (little bit of soreness). On 14-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch), VACCINATION SITE INDURATION (It is hard), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE PRURITUS (Itching), FATIGUE (felt tired) and VACCINATION SITE SWELLING (Swelling). On 08-Jan-2021, VACCINATION SITE PAIN (little bit of soreness) had resolved. At the time of the report, VACCINATION SITE WARMTH (Hot to touch), VACCINATION SITE INDURATION (It is hard), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE PRURITUS (Itching), FATIGUE (felt tired) and VACCINATION SITE SWELLING (Swelling) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: No new information reported; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Arm is swelling up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm is swelling up) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm is swelling up). At the time of the report, PERIPHERAL SWELLING (Arm is swelling up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Pt recv vax on 10/9/96; on 10/10/96 pt exp hives on trunk & extremities x 48 hr; tx=Benadryl
Pt report tingling sensation to left forearm about 5 mins after administration of vaccine Reassurance provided  Monitor for 45 mins report slight improvement in tingling sensation denies SOB, no difficulty breathing, no chills, no hives, no swelling in throat No signs of acute distress  Pt educated to follow up PCP if symptoms gets worse or doesn't resolve ER precaution provided Pt verbalized understanding
TDAP vaccine administered at approx. 10:15am.  Employee noted a sensation in her right neck and jaw, reports she can feel vaccine in those areas.  This occurred only moments after the vaccine was injected.   Vaccine was administered on 03/22/21, employee calls clinic today 3/23/21 to report persistence of symptoms.
Information has been received from a medical assistant referring to multiple patients of unknown ages and genders. The patients' medical histories and concurrent conditions were not reported. On unspecified dates the patients were vaccinated with improperly stored doses of VARIVAX (lot # L45953, expiration date 17-NOV-2017) subcutaneous. Concomitant therapy was not reported. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
After vaccination, while waiting the recommended 15 minutes post vaccination, around 10 minutes, patient fainted and eyes rolled back, patient was limb and could not stand. Patient was breathing and talking, however was disoriented, did not know where she was.
With the first dose I had chills, but with the second dose I had chills as well but about a week later I was starting to have hiccup-burps. I started taking antacids, and they didn't disappear but they lessened in intensity. I didn't see a doctor at the time because I wasn't sure if It was connected, and I don't have insurance. I also experienced some Covid-like symptoms, chills and body aches.
Total body chills in middle of night when I got up to go to the bathroom.  Uncontrollable shaking over my entire body.  Only lasted for two or three minutes until I got back in bed and under the covers.  Same thing happened two nights later about the same time, but I never got out of bed then and it only lasted for a minute or so.  It was much less severe and was limited more to my upper body.  I was fine both times when I got up in the morning.
Pt vaxed 28OCT91 & on 3NOV91 seen in ER; unable to move arm-very painful dx inflammation of the tendon; afebrile; tx included anti-inflammatory meds; 4NOV91 pt improving;
Low-grade fever (99.6 degrees F), chills, swollen and pain in my right arm as well as fatigue that lasted for ~ 24 hours.  General fatigue continues to persist while other symptoms have resolved.  I did not take any pain or fever reducing medication.
Patient called the pharmacy on 2/8/23 reporting soreness, redness, swelling, itching, and tenderness at and around injection site. Patient reports no swelling of lips, tongue, or shortness of breath or difficulty swallowing or breathing. I advised patient to take Motrin, Benadryl, and to ice the area. I also advised her to call me back if it wasn't getting better. Patient called back and reported slight worsening of symptoms. I advised patient to call her doctor. She stated she was going to urgent care. I told her to have the physician call me if there were any more questions.